NCT03337048

Brief Summary

The objective of the study is to explore and understand how urodynamic parameters are affected when emptying the bladder with an intermittent catheter.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 7, 2017

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 8, 2017

Completed
22 days until next milestone

Study Start

First participant enrolled

November 30, 2017

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 29, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 29, 2018

Completed
6.2 years until next milestone

Results Posted

Study results publicly available

August 12, 2024

Completed
Last Updated

August 12, 2024

Status Verified

March 1, 2024

Enrollment Period

6 months

First QC Date

November 7, 2017

Results QC Date

January 31, 2020

Last Update Submit

March 12, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Discomfort During Catheter Insertion on a Visual Analogue Scale

    On a scale ranging from 0 "no discomfort" to 10 "worst possible discomfort" caused by the catheter, set a vertical line indicating how you experienced the insertion of the catheter. Higher scores mean a worse outcome.

    Filled out after 5 minutes per catheterisation.

Study Arms (1)

Measurement of endpoints

EXPERIMENTAL

In healthy volunteers the endpoint are measured while spontaneous voiding of the bladder and while emptying the bladder using a standard intermittent catheter. In subjects with spinal cord injury or enlarged prostata the endpoint are measured while emptying the bladder using a standard intermittent catheter.

Device: SpeediCath

Interventions

SpeediCath is a standard intermittent catheter that is on the market.

Measurement of endpoints

Eligibility Criteria

Age18 Years+
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsOnly male subjects are included as the intermittent catheter used in the investigation is a male catheter
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Have given written informed consent
  • Be at least 18 years of age and have full legal capacity
  • Be male
  • For healthy volunteers: Willing to comply with not using analgesics up to 24 hours prior to study visit
  • For healthy volunteers: Negative urine multistix (leukocytes and nitrite), or if positive, subsequent negative for bacterial growth in urine culture
  • For SCI and BPH patients: Use intermittent catheter daily and have used intermittent catheters for at least 2 months

You may not qualify if:

  • Symptoms of urinary tract infections (frequent urination, stinging and pain at urination)
  • For healthy volunteers: Abnormalities, diseases or surgical procedures performed in the lower urinary tract

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Urology, Rigshospitalet

Copenhagen, 2100, Denmark

Location

MeSH Terms

Conditions

Spinal Cord Injuries

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Results Point of Contact

Title
Vice President, Medical Affairs
Organization
Coloplast A/S

Study Officials

  • Nazarena Mazarro

    Vice president Medical Affairs

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
Yes
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 7, 2017

First Posted

November 8, 2017

Study Start

November 30, 2017

Primary Completion

May 29, 2018

Study Completion

May 29, 2018

Last Updated

August 12, 2024

Results First Posted

August 12, 2024

Record last verified: 2024-03

Locations